Axim Biotechnologies Stock Analysis
| AXIM Stock | USD 0 0.0002 6.67% |
Axim Biotechnologies is overvalued with Real Value of 0.002339 and Hype Value of 0.00194. The main objective of Axim Biotechnologies pink sheet analysis is to determine its intrinsic value, which is an estimate of what Axim Biotechnologies is worth, separate from its market price. There are two main types of Axim Biotechnologies' stock analysis: fundamental analysis and technical analysis.
The Axim Biotechnologies pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Axim |
Axim Pink Sheet Analysis Notes
About 41.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.13. Axim Biotechnologies had not issued any dividends in recent years. AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California. Axim Biotechnologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.The quote for Axim Biotechnologies is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Axim Biotechnologies please contact John II at 858 923 4422 or go to https://www.aximbiotech.com.Axim Biotechnologies Investment Alerts
| Axim Biotechnologies is way too risky over 90 days horizon | |
| Axim Biotechnologies has some characteristics of a very speculative penny stock | |
| Axim Biotechnologies appears to be risky and price may revert if volatility continues | |
| Axim Biotechnologies has high likelihood to experience some financial distress in the next 2 years | |
| Axim Biotechnologies currently holds 5.06 M in liabilities with Debt to Equity (D/E) ratio of 1.36, which is about average as compared to similar companies. Axim Biotechnologies has a current ratio of 0.06, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Axim Biotechnologies until it has trouble settling it off, either with new capital or with free cash flow. So, Axim Biotechnologies' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Axim Biotechnologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Axim to invest in growth at high rates of return. When we think about Axim Biotechnologies' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 60.46 K. Net Loss for the year was (16.03 M) with profit before overhead, payroll, taxes, and interest of 60.46 K. | |
| Axim Biotechnologies currently holds about 65.16 K in cash with (2.49 M) of positive cash flow from operations. | |
| Roughly 41.0% of Axim Biotechnologies shares are held by company insiders |
Axim Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Axim Biotechnologies's market, we take the total number of its shares issued and multiply it by Axim Biotechnologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 24th of March, Axim Biotechnologies shows the Mean Deviation of 5.36, risk adjusted performance of 0.0939, and Standard Deviation of 14.73. Axim Biotechnologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Axim Biotechnologies coefficient of variation and maximum drawdown to decide if Axim Biotechnologies is priced correctly, providing market reflects its regular price of 0.0032 per share. As Axim Biotechnologies appears to be a penny stock we also recommend to validate its jensen alpha numbers.Axim Biotechnologies Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Axim Biotechnologies middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Axim Biotechnologies. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Axim Biotechnologies Outstanding Bonds
Axim Biotechnologies issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Axim Biotechnologies uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Axim bonds can be classified according to their maturity, which is the date when Axim Biotechnologies has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US05464HAB69 Corp BondUS05464HAB69 | View | |
| AXIS SPECIALTY FIN Corp BondUS05464HAC43 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| US05463HAB78 Corp BondUS05463HAB78 | View | |
| US05463HAC51 Corp BondUS05463HAC51 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Axim Biotechnologies Predictive Daily Indicators
Axim Biotechnologies intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Axim Biotechnologies pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.07 | |||
| Day Median Price | 0.0032 | |||
| Day Typical Price | 0.0032 | |||
| Price Action Indicator | 1.0E-4 | |||
| Period Momentum Indicator | 2.0E-4 |
Axim Biotechnologies Forecast Models
Axim Biotechnologies' time-series forecasting models are one of many Axim Biotechnologies' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Axim Biotechnologies' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Axim Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Axim Biotechnologies prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Axim shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Axim Biotechnologies. By using and applying Axim Pink Sheet analysis, traders can create a robust methodology for identifying Axim entry and exit points for their positions.
AXIM Biotechnologies, Inc. develops and sells diagnostic healthcare solutions in the areas of SARS-CoV-2, eye health, and oncology. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California. Axim Biotechnologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Axim Biotechnologies to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Other Information on Investing in Axim Pink Sheet
Axim Biotechnologies financial ratios help investors to determine whether Axim Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Axim with respect to the benefits of owning Axim Biotechnologies security.